LifeSensors ubiquitin ligase and proteasome inhibitors

Tuesday, 12 November, 2013 | Supplied by: United Bioresearch Products Pty Ltd

LifeSensors ubiquitin ligase and proteasome inhibitors

LifeSensors has added several small molecule ubiquitin ligase and proteasome inhibitors to its range.

Carfilzomib is the active ingredient in the new clinical proteasome inhibitor Kyprolis.

Epoxomicin/BU-4061T is one of the most potent and selective proteasome inhibitors.

Oprozomib/ONX0912 is a clinical-stage proteasome inhibitor that selectively inhibits the chymotrypsin-like activity of the 20S proteasome.

MLN2238 is a potent inhibitor of the chymotrypsin-like activity of the 20S proteasome.

RITA/NSC652287 blocks p53-hdm2 interaction and p53 ubiquitination.

SKPin C1 inhibits the cullin-RING ubiquitin E3 ligase SCF-Skp2.

Online: www.unitedbioresearch.com.au
Phone: 02 4575 0309
Related Products

Navinci NaveniFlex Tissue Red proximity ligation assay kit

The kit enables fluorescence visualisation of protein–protein interactions or...

Bio-Rad Laboratories StarBright Dyes for spectral flow cytometry

The range provides users with more options when designing spectral flow cytometry panels,...

MaxWell Biosystems MaxOne+ HD-MEA Chip

The MaxOne+ HD-MEA Chip provides an upgraded performance and user experience through...


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd